CompoAtlas

LAC Men's Horny Goat Weed Plus Capsule

LAC Men's Horny Goat Weed Plus Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lepidium meyeniiLepidium meyenii[125.00 mg,470.00 mg]Not identified
Epimedium sagittatumEpimedium sagittatum[300.00 mg,470.00 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL22046081TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
LAC GLOBAL BRANDS (MALAYSIA) SDN. BHD.
Manufacturer
ARNET PHARMACEUTICAL CORPORATION
Importer
LAC GLOBAL BRANDS (MALAYSIA) SDN. BHD.
Registration period starting
2022-04-08
Published validity end
2027-04-08

Original register data

View published fields and their variants
Active ingredients
Lepidium meyenii[125.00 mg,470.00 mg],Epimedium sagittatum[300.00 mg,470.00 mg]
Valid until
2027-04-08
Registration date
2022-04-08
Published description
NATURAL PRODUCT
Licence holder
LAC GLOBAL BRANDS (MALAYSIA) SDN. BHD.
Importer
LAC GLOBAL BRANDS (MALAYSIA) SDN. BHD.
Producer
ARNET PHARMACEUTICAL CORPORATION
Published name
LAC Men's Horny Goat Weed Plus Capsule
Published reference
202201046459T
Registration number
MAL22046081TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22046081TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Lepidium meyenii
    Read the warning, when it applies and the studies cited

    Maca - Lepidium Meyenii

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    Sources cited by Health Canada (1)
    • Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (2)
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Condition of application: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (3)
    • Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Review article
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Health Canada monograph dated 27 September 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “LAC Men's Horny Goat Weed Plus Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL22046081TC-lac-men-s-horny-goat-weed-plus-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line